Composition
- Active ingredients
- TIVOZANIB 1.34MG
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application ANDA220437.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Tivozanib
- Dosage form
- Capsule
- Applicant
- Sandoz Inc
- Status
- Tentative approval
- FDA approval
- 14 May 2026
- Application
- ANDA220437-002